IGH switch breakpoints in Burkitt lymphoma: Exclusive involvement of noncanonical class switch recombination

Genes Chromosomes and Cancer

Volumn 45, Issue 9, 2006, Pages 808-819

  Guikema, Jeroen E J ^a,c   De Boer, Conny ^a   Haralambieva, Eugenia ^a   Smit, Laura A ^b   Van Noesel, Carel J M ^b   Schuuring, Ed ^a   Kluin, Philip M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN M;

ADOLESCENT; ALLELE; ARTICLE; BURKITT LYMPHOMA; CHILD; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE REARRANGEMENT; GENE SWITCHING; GENETIC MARKER; GENETIC RECOMBINATION; HUMAN; MALE; NONCANONICAL CLASS SWITCH RECOMBINATION; ONCOGENE MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ADOLESCENT; ALLELES; BURKITT LYMPHOMA; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CHROMOSOME BREAKAGE; FEMALE; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN HEAVY CHAINS; MALE;

EID: 33746788256     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20345     Document Type: Article

References (44)

1. Basaki Y, Ikizawa K, Kajiwara K, Yanagihara Y. 2002. CD40-mediated tumor necrosis factor receptor-associated factor 3 signaling upregulates IL-4-induced germline C-ε transcription in a human B cell line. Arch Biochem Biophys 405:199-204.
2. Basso K, Frascella E, Zanesco L, Rosolen A. 1999. Improved long-distance polymerase chain reaction for the detection of t(8;14) (q24;q32) in Burkitt's lymphomas. Am J Pathol 155:1479-1485.
3. Bemark M, Neuberger MS. 2003. By-products of immunoglobulin somatic hypermutation. Genes Chromosomes Cancer 38:32-39.
4. Bergsagel PL, Kuehl WM. 2001. Chromosome translocations in multiple myeloma. Oncogene 20:5611-5622.
5. Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. 1996. Dysregulation of cyclin D1 by translocation into an IgHγ switch region in two multiple myeloma cell lines. Blood 88:2871-2878.
6. Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schrock E, Ried T, Kuehl WM. 1998. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91:4457-4463.
7. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL. 1997. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260-264.
8. Chesi M, Nardini E, Lim RSC, Smith KD, Kuehl WM, Bergsagel PL. 1998. The t(4;14) translocation in multiple myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92:3025-3034.
9. Coffman RL, Lebman DA, Rothman P. 1993. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 54:229-270.
10. Dudley DD, Manis JP, Zarrin AA, Kaylor L, Tian M, Alt FW. 2002. Internal IgH class switch region deletions are position-independent and enhanced by AID expression. Proc Natl Acad Sci USA 99:9984-9989.
11. Fenton JA, Pratt G, Rawstron AC, Sibley K, Rothwell D, Yates Z, Dring A, Richards SJ, Ashcroft AJ, Davies FE, Owen RG, Child JA, Morgan GJ. 2003. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism. Oncogene 22:1103-1113.
12. + human B cell lymphoma. J Immunol 160:595-605.
13. Gilles F, Goy A, Remache Y, Shue P, Zelenetz AD. 2000. MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma. Blood 95:2930-2936.
14. Guikema JE, Fenton JA, de Boer C, Kleiverda K, Brink AA, Raap AK, Estrov Z, Schuuring E, Kluin PM. 2005. Complex biallelic IGH rearrangements in IgM-expressing Z-138 cell line: Involvement of downstream immunoglobulin class switch recombination. Genes Chromosomes Cancer 42:164-169.
15. Gutierrez MI, Bhatia K, Barriga F, Diez B, Muriel FS, Deandreas ML, Epelman S, Risueno C, Magrath IT. 1992. Molecular epidemiology of Burkitt-lymphoma from South-America-Differences in break-point location and Epstein-Barr-Virus association from tumors in other world regions. Blood 79:3261-3266.
16. Haralambieva E, Schuuring E, Rosati S, van Noesel C, Jansen P, Appel I, Guikema J, Wabinga H, Bleggi-Torres LF, Lam K, van den Berg E, Mellink C, Zelderen-Bhola S, Kluin P. 2004. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: Validation in Burkitt lymphomas from three geographic regions. Genes Chromosomes Cancer 40:10-18.
17. Ichiki T, Takahashi W, Watanabe T. 1992. The effect of cytokines and mitogens on the induction of Cε germline transcripts in a human Burkitt lymphoma B cell line. Int Immunol 4:747-754.
18. Ichiki T, Takahashi W, Watanabe T 1993. Regulation of the expression of human Cε germline transcript. Identification of a novel IL-4 responsive element. J Immunol 150:5408-5417.
19. Ikizawa K, Yanagihara Y. 2000. Possible involvement of She in IL-4-induced germline ε transcription in a human B cell line. Biochem Biophys Res Commun 268:54-59.
20. Khamlichi AA, Glaudet F, Oruc Z, Denis V, Le Bert M, Cogne M. 2004. Immunoglobulin class-switch recombination in mice devoid of any Sμ tandem repeat. Blood 103:3828-3836.
21. Kuehl WM, Bergsagel PL. 2002. Multiple myeloma: Evolving genetic events and host interactions. Nat Rev Cancer 2:175-187.
22. Küppers R, Dalla-Favera R. 2001. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20:5580-5594.
23. Lenoir GM, Vuillaume M, Bonnardel C. 1985. The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. IARC Sci Publ 60:309-318.
24. McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK, Dube I, Sandberg AA, Rowley JD. 1997. BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: A molecular and cytogenetic study. Genes Chromosomes Cancer 20:64-72.
25. Muller JR, Janz S, Potter M. 1995. Differences between Burkitts lymphomas and mouse plasmacytomas in the immunoglobulin heavy-chain c-myc recombinations that occur in their chromosomal translocations. Cancer Res 55:5012-5018.
26. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-563.
27. Nambu Y, Sugai M, Gonda H, Lee CG, Katakai T, Agata Y, Yokota Y, Shimizu A. 2003. Transcription-coupled events associating with the immunoglobulin switch region chromatin. Science 302:2137-2140.
28. Nardini E, Aiello A, Giardini R, Colnaghi MI, Menard S, Balsari A. 2000. Detection of aberrant isotype switch recombination in low-grade and high-grade gastric MALT lymphomas. Blood 95:1032-1038.
29. Nardini E, Rizzi S, Capello D, Vitolo U, Gaidano G, Menard S, Balsari A. 2002. Most immunoglobulin heavy chain switch μ rearrangements in B-cell chronic lymphocytic leukemia are internal deletions. FEBS Lett 518:119-123.
30. Neri A, Barriga F, Knowles IDM, Magrath IT, Dalla-Favera R. 1988. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt-lymphoma. Proc Natl Acad SCi USA 85:2748-2752.
31. Ohno H, Doi S, Yabumoto K, Fukuhara S, McKeithan TW. 1993. Molecular characterization of the t(14;19)(q32;q13) translocation in chronic lymphocytic leukemia. Leukemia 7:2057-2063.
32. Pelicci PG, Knowles DM, Magrath IT, Dalla-Favera R. 1986. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt-lymphoma. Proc Natl Acad Sci USA 83:2984-2988.
33. Ramiro AR, Jankovic M, Gallen E, Difilippantonio S, Chen HT, McBride KM, Eisenreich TR, Chen J, Dickins RA, Lowe SW, Nussenzweig A, Nussenzweig MC. 2006. Role of genomic instability and p53 in AID-induced e-myc-Igh translocations. Nature 440:105-109.
34. Revy P, Muto T, Levy Y, Geissman F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcc-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102:565-575.
35. Schmidt HH, Dyomin VG, Palanisamy N, Itoyama T, Nanjangud G, Pirc-Danoewinata H, Haas OA, Chaganti RS. 2004. Deregulation of the carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11) gene in a B-cell chronic lymphocytic leukemia with a t(12;14)(q23;q32). Oncogene 23:6991-6996.
36. Showe LC, Ballantine M, N shikura K, Erikson J, Kaji H, Croce CM. 1985. Cloning and sequencing of a c-myc oncogene in Burkitt's lymphoma cell line that is translocated to a germline α switch region. Mol Cell Biol 5:501-509.
37. Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, van Noesel CJ. 2003. Expression of the activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 63:3894-3898.
38. Stavnezer J. 1996. Antibody class switching. Adv Immunol 61:79-146.
39. Stavnezer-Nordgren J, Sirlin S. 1986. Specificity of immunoglobulin heavy chain switch correlates with activity of germline heavy chain genes prior to switching. EMBO J 5:95-102.
40. Unniraman S, Zhou S, Schatz DG. 2004. Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc. Nat Immunol 5:1117-1123.
41. Vaandrager JW, Schuuring E, Kluin-Nelemans HC, Dyer MJ, Raap AK, Kluin PM. 1998. DNA fiber fluorescence in situ hybridization analysis of immunoglobulin class switching in B-cell neoplasia: Aberrant C-H gene rearrangements in follicle center-cell lymphoma. Blood 92:2871-2878.
42. Wilda M, Busch K, Klose I, Keller T, Woessmann W, Kreuder J, Harbott J, Borkhardt A. 2004. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus. Genes Chromosomes Cancer 41:178-182.
43. Yu K, Chedin F, Hsieh CL, Wilson TE, Lieber MR. 2003. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat Immunol 4:442-451.
44. Zhang K, Cheah HK, Saxor A. 1995. Secondary deletional recombination of rearranged switch region in isotype-switched B cells. A mechanism for isotype stabilization. J Immunol 154:2237-2247.